EyeCool Therapeutics

Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of a novel device-based technology designed to focus on developing innovative treatments for Chronic Ocular Surface Pain (COSP). EyeCool Therapeutics is based in Cambridge, MA and was founded in 2021. It has raised $12.5 million.

Last price · $/share
—
Implied valuation
—
Total raised
$12.5M
Last round
—

Who backs EyeCool Therapeutics?

6 investors
InvestorType
PV Capital ManagementFamily office
Angel Physicians Fund—
Catalyst Health Ventures—
Excelestar Ventures—
Hub Angels Investment Group—
LaunchCapital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

EyeCool Therapeutics investors

6 investors are on record for EyeCool Therapeutics, including PV Capital Management, Angel Physicians Fund, Catalyst Health Ventures and Excelestar Ventures.

Free account
More of EyeCool Therapeutics with a free account
  • ·Watch EyeCool Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like EyeCool Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View